Company Profiles

driven by the PitchBook Platform

Odin Biotech Partners

Odin Biotech Partners
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$2.2M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of drugs for diseases of the retina. The company develops novel therapeutics for debilitating ophthalmic diseases which can be used for the treatment of wet age-related macular degeneration.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
4441 Buena Vista Street
Dallas, TX 75205
United States

+1 (469) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Odin Biotech Partners’s full profile, request a free trial.

Odin Biotech Partners Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 28-Aug-2014 $2.2M 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Odin Biotech Partners Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Claria Bioscience Other Minority 000 0000 000000 0
2M Companies Family Office Minority 000 0000 000000 0

Odin Biotech Partners Executive Team (1)

Name Title Board
Seat
Contact
Info
Karl Csaky Ph.D Founder, Chief Medical Officer, Chief Executive Officer & Board Member

Odin Biotech Partners Board Members (2)

Name Representing Role Since Contact
Info
Karl Csaky Ph.D Odin Biotech Partners Founder, Chief Medical Officer, Chief Executive Officer & Board Member 000 0000
Melissa Krauth 2M Companies Board Member & Interim CEO 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com